Big4Bio Podcast: How a Long Effort to Protect Against RSV May Lead to a Better COVID-19 Vaccine

As part of Big4Bio's Company to Watch program, we spoke to Marty Moore, founder and CEO of Meissa Vaccines, about Meissa’s platform technology, how it works, and why its approach could provide significant benefits over existing COVID-19 vaccine.


To listen to the podcast, click here.